Genitourinary Cancer

Panel 03 - (INTERACTIVE) Hypofractionated Radiation Therapy for Localized Prostate Cancer: ASTRO, ASCO, and AUA Guideline Recommendations and Evidentiary Base

Introduction to ASTRO clinical practice guidelines and development of the prostate hypofractionation guideline

Sunday, October 21
4:45 PM - 5:03 PM
Location: Lila Cockrell Theatre

Scott Morgan, MD, MSc, FRCPC

Disclosure:
Employment
The Ottawa Hospital Cancer Centre: Radiation Oncologist: Independent Contractor

Compensation
Astellas: Advisory Board, Honoraria; Janssen: Advisory Board, Honoraria

Leadership
American Society of Clinical Oncology: Co-Chair

Biography:
Dr. Scott Morgan is a radiation oncologist at The Ottawa Hospital Cancer Centre and an Assistant Professor in the Division of Radiation Oncology at the University of Ottawa, Canada. He holds a Bachelor of Applied Science in Engineering Physics from the University of British Columbia, a Doctor of Medicine from Queen’s University, and a Master of Science in Clinical Trials from the University of London. Prior to starting his practice in Ottawa in 2010, he completed a fellowship in genitourinary clinical oncology at The Royal Marsden Hospital in London. His practice is focused on genitourinary and breast malignancy. He is a longstanding member of the Genitourinary Disease Site Group of the Cancer Care Ontario Programme in Evidence-Based Care. Since 2016, he has served as Co-Chair of the Genitourinary Guideline Advisory Group of the American Society of Clinical Oncology.

Presentation(s):

Send Email for Scott Morgan


Assets

Introduction to ASTRO clinical practice guidelines and development of the prostate hypofractionation guideline

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Introduction to ASTRO clinical practice guidelines and development of the prostate hypofractionation guideline